{
    "clinical_study": {
        "@rank": "62224", 
        "acronym": "taperloc", 
        "arm_group": [
            {
                "arm_group_label": "Taperloc Complete Standard", 
                "arm_group_type": "Active Comparator", 
                "description": "Group one will receive a total hip replacement with Taperloc Complete Standard. Taperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques."
            }, 
            {
                "arm_group_label": "Taperloc Complete Microplasty", 
                "arm_group_type": "Active Comparator", 
                "description": "Group one will receive a total hip replacement with Taperloc Complete Microplasty.Taperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to measure the postoperative changes in bone mineral\n      density, comparing the Taperloc Complete Reduced Distal Microplasty stem and the standard\n      length Taperloc Complete Reduced Distal stem."
        }, 
        "brief_title": "Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Osteoarthritis", 
            "Avascular Necrosis", 
            "Traumatic Arthritis", 
            "Rheumatoid Arthritis", 
            "Legg-Perthes Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Legg-Perthes Disease", 
                "Necrosis", 
                "Osteonecrosis", 
                "Osteoarthritis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Taperloc Microplasty cementless stem is designed to transmit load to the proximal femur,\n      thereby preserving bone density, and preventing long term instability and loosening\n      secondary to proximal bone resorption.   The primary aim of this study is therefore to\n      compare the postoperative changes in bone density with the Taperloc Microplasty stem, using\n      the standard length Taperloc stem as a control.\n\n      In addition, the Taperloc stem has historically had a neck angle of 138\u00b0.   There have been\n      criticisms that this neck angle is too high for the typical Korean population.    The newer\n      Taperloc Complete system (both Microplasty and standard length) has a neck angle of 133\u00b0.\n      A secondary aim is Occurrence ratio of thigh pain difference between Microplasty and\n      standard stem in Korean Population"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients suitable for primary Total Hip Replacement\n\n        Patients with degenerative joint disease (inflammatory or non-inflammatory) or any of the\n        composite diagnoses of:\n\n          1. Osteoarthritis\n\n          2. Avascular necrosis\n\n          3. Legg Perthes\n\n          4. Rheumatoid Arthritis\n\n          5. Diastrophic variant\n\n          6. Fused hip\n\n          7. Sequelae of Slipped capital epiphysis\n\n          8. Traumatic arthritis\n\n          9. Patients aged over 20\n\n         10. Patients must be able to understand instructions and be willing to return for\n             follow-up\n\n        Exclusion Criteria:\n\n          -  Absolute contraindications include: infection, sepsis, and osteomyelitis.\n\n        Relative contraindications include:\n\n          1. uncooperative patient or patient with neurologic disorders who are incapable of\n             following directions,\n\n          2. Small Femoral canal\n\n        2) Severe osteoporosis (Patients over 65 years old) 3) metabolic disorders which may\n        impair bone formation, 4) osteomalacia, 5) distant foci of infections which may spread to\n        the implant site, 6) rapid joint destruction, marked bone loss or bone resorption apparent\n        on roentgenogram, and 7) vascular insufficiency, muscular atrophy, or neuromuscular\n        disease. 8) pregnancy 9) Fracture of the pelvis 10) Subcapital fractures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087436", 
            "org_study_id": "INT.CR.GH3.13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Taperloc Complete Microplasty", 
                "description": "Taperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption.", 
                "intervention_name": "Taperloc Complete Microplasty", 
                "intervention_type": "Device", 
                "other_name": "Taperloc Complete Microplasty"
            }, 
            {
                "arm_group_label": "Taperloc Complete Standard", 
                "description": "Taperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques.", 
                "intervention_name": "Taperloc Complete Standard", 
                "intervention_type": "Device", 
                "other_name": "Taperloc Complete Standard"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 1, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Young-Kyun Lee, PHD", 
                    "phone": "821090902468"
                }, 
                "facility": {
                    "address": {
                        "city": "Gyeonggi-do", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Bundang Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yong-Chan Ha, PHD", 
                    "phone": "821195218328"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chung-Ang University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density", 
        "overall_contact": {
            "email": "ykleemd@gmail.com", 
            "last_name": "Young Kyun Lee, PHD", 
            "phone": "82-10-9090-2468"
        }, 
        "overall_official": [
            {
                "affiliation": "Chung-Ang University Hospital", 
                "last_name": "Yong-Chan Ha, PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Seoul National University Bundang Hospital", 
                "last_name": "Young-Kyun Lee, PHD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "evaluate bone mineral density around the implant", 
            "measure": "Bone Mineral Density", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087436"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Radiographic measurements of stability and fixation", 
                "measure": "Radiographic Evaluation,", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "The measurement of pain intensity", 
                "measure": "VAS Score", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Over all Survivorship\nHarris Hip Score", 
                "measure": "Modified Harris Hip Score", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Radiographic measurements of stability and fixation", 
                "measure": "Radiographic Evaluation", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Radiographic measurements of stability and fixation", 
                "measure": "Radiographic Evaluation", 
                "safety_issue": "No", 
                "time_frame": "6 Weeks"
            }, 
            {
                "description": "The measurement of pain intensity", 
                "measure": "VAS Score", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "The measurement of pain intensity", 
                "measure": "VAS Score", 
                "safety_issue": "No", 
                "time_frame": "6 Weeks"
            }, 
            {
                "description": "The measurement of pain intensity", 
                "measure": "VAS Score", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }, 
            {
                "description": "Over all Survivorship\nHarris Hip Score", 
                "measure": "Modified Harris Hip Score", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Over all Survivorship\nHarris Hip Score", 
                "measure": "Modified Harris Hip Score", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }, 
            {
                "description": "Two X-ray beams with different energy levels are aimed at the patient's bones.\nDEXA\nevaluate the bone mineral density around the implant", 
                "measure": "Bone Mineral Density", 
                "safety_issue": "No", 
                "time_frame": "Immediate post-op(2 - 4Weeks)"
            }
        ], 
        "source": "Biomet, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biomet, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}